Sergio Nuñez de Arenas-Arroyo

Mr. Sergio Nuñez de Arenas-Arroyo

Universidad de Castilla-La Mancha, Cuenca, Spain
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ISIrene Sequí-Domínguez
Irene Sequí-Domínguez
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
CÁCelia Álvarez-Bueno
Celia Álvarez-Bueno
Diana P. Pozuelo-CarrascosaDiana P. Pozuelo-Carrascosa
Diana P. Pozuelo-Carrascosa
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
Increased arterial stiffness has been associated with an increased risk of developing cardiovascular diseases and all-cause mortality. Pulse wave velocity (PWV) is an innovative and affordable measurement of arterial stiffness which may be an accessible tool to estimate mortality risk; however, no meta-analysis has estimated its predictive performance for cardiovascular and all-cause mortality. Moreover, reference values for PWV have only been established by consensus for healthy populations. The aim of this review was to estimate PWV and especially carotid femoral PWV performance predicting cardiovascular and all-cause mortality as well as comparing the resulting cfPWV thresholds with already established values in order to increase its validity. Original studies measuring PWV thresholds and its association with cardiovascular and all-cause mortality were systematically searched. The DerSimonian and Laird method was used to compute pooled estimates of diagnostic odds ratio (dOR), and overall test performances were summarized in hierarchical summary receiver operating characteristic curves (HSROC). Six studies were included in the meta-analysis. The pooled dOR values for the predictive performance of cfPWV were 11.23 (95 % CI, 7.29–1.29) for cardiovascular mortality and 6.52 (95% CI, 4.03–10.55) for all-cause mortality. The area under the HSROC curve for cfPWV was 0.75 (95% CI, 0.69–0.81) for cardiovascular mortality and 0.78 (95% CI, 0.74–0.83) for all-cause mortality, where the closest cut-off point to the summary point was 10.7 and 11.5, respectively. This systematic review and meta-analysis demonstrates that cfPWV is a useful and accurate cardiovascular mortality predictor and that its previously estimated reference values for estimating risk may be used in high-risk populations.

1 January 2024 in Nutrition Reviews
Verified
Journal Article
Closed access
PDF file
BPBruno Bizzozero Peroni
Bruno Bizzozero Peroni
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
Rubén Fernández-RodríguezRubén Fernández-Rodríguez
Rubén Fernández-Rodríguez
EJEstela Jiménez-López
Estela Jiménez-López
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
AMArthur Eumann Mesas
Arthur Eumann Mesas
High adherence to the Mediterranean diet (MD) has been associated with a reduced risk of depression in prospective cohort studies, but whether MD interventions are effective among adults with depression is uncertain. This study aimed to synthesize findings on the effects of MD interventions on the severity of depressive symptoms in adults with depression. PubMed, Cochrane CENTRAL, PsycINFO, Scopus, and Web of Science were systematically searched from database inception to March 2023. The Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines and the Cochrane recommendations were followed. We included randomized controlled trials (RCTs) comparing outcomes after MD interventions with outcomes for control conditions in adults with depressive disorders or depressive symptoms. Two authors extracted the data independently. The Sidik-Jonkman estimator, the I2 metric, and the prediction interval were used to estimate between-study heterogeneity. To determine the risk of bias and the certainty of evidence from RCTs, we used the Cochrane Collaboration’s Risk of Bias 2 and Grades of Recommendation, Assessment, Development, and Evaluation tools, respectively. In total, 1507 participants (mean age range: 22.0 years–53.3 years) with depression were initially included in the 5 RCTs of this review. Compared with control conditions, MD interventions significantly reduced depressive symptoms among young and middle-aged adults with major depression or mild to moderate depressive symptoms (standardized mean difference: –0.53; 95% confidence interval: –0.90 to –0.16; I2 = 87.1%). The prediction interval ranged from –1.86 to 0.81. The overall risk of bias was within the range of “some concerns” to “high,” while the certainty of evidence was low. MD interventions appear to have substantial potential for alleviating depressive symptoms in people experiencing major or mild depression. However, to establish robust recommendations, there remains a need for high-quality, large-scale, and long-term RCTs. PROSPERO registration no. CRD42022341895.

23 January 2023 in British Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
AMArthur Eumann Mesas
Arthur Eumann Mesas
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
MGMiriam Garrido-Miguel
Miriam Garrido-Miguel
Rubén Fernández-RodríguezRubén Fernández-Rodríguez
Rubén Fernández-Rodríguez
ATAna Torres-Costoso
Ana Torres-Costoso
Objective: To estimate the association between daytime napping and cognitive and physical sport performance and fatigue after normal sleep and partial sleep deprivation (less sleep duration than necessary). Design: Systematic review and meta-analysis. Data sources: The PubMed, Scopus, Web of Science, Cochrane Central, SportDiscus and PsycINFO databases. Eligibility criteria for selecting studies: Randomised controlled trials on the effect of daytime napping on sport performance and fatigue available from inception to 2 December 2022. Standardised mean differences (SMD) and their 95% compatibility intervals (CI) were estimated with the DerSimonian-Laird method through random effect models. Results: In the 22 included trials, 291 male participants (164 trained athletes and 127 physically active adults) aged between 18 and 35 years were studied. When performed after a normal night of sleep, napping from 12:30 hours to 16:50 hours (with 14:00 hours being the most frequent time) improved cognitive (SMD=0.69, 95% CI: 0.37 to 1.00; I2=71.5%) and physical performance (SMD=0.99, 95% CI: 0.67 to 1.31; I2=89.1%) and reduced the perception of fatigue (SMD=−0.76, 95% CI: −1.24 to –0.28; I2=89.5%). The positive effects of napping were also confirmed after partial sleep deprivation. Overall, the benefits were higher with a nap duration between 30 and <60 min and when the time from nap awakening to test was greater than 1 hour. Conclusions: After a night of normal sleep or partial sleep deprivation, a daytime nap between 30 and <60 min has a moderate-to-high effect on the improvement of cognitive performance and physical performance and on the reduction of perceived fatigue. PROSPERO registration number: CRD42020212272.

6 December 2020 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Closed access
PDF file
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
CÁCelia Álvarez-Bueno
Celia Álvarez-Bueno
ISIrene Sequí-Domínguez
Irene Sequí-Domínguez
SRSara Reina-Gutiérrez
Sara Reina-Gutiérrez
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino

3 April 2023 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Open access
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
ATAna Torres-Costoso
Ana Torres-Costoso
SRSara Reina-Gutiérrez
Sara Reina-Gutiérrez
PLPatricia Lorenzo‐García
Patricia Lorenzo‐García
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
Objectives: The two aims of this systematic review and meta‐analysis were to (1) analyze the effect of exercise on chemotherapy‐induced peripheral neuropathy (CIPN) severity and (2) determine the best type of exercise for the management of CIPN.Methods: We systematically searched the MEDLINE, WOS, Sportdiscus, Scopus, and Cochrane databases from inception to December 2020 for experimental studies addressing the effect of exercise on CIPN severity, as measured by symptom severity (SSS) and peripheral deep sensitivity (PDS). The DerSimonian and Laird method was used to compute pooled estimates of the standardized mean differences (SMDs) and its respective 95% confidence intervals (CIs). Subgroup analyses were performed based on the types of exercise and the frequency and length of the interventions.Results: Thirteen studies were included in this meta‐analysis. In the analyses comparing exercise interventions versus controls, there was an improvement in the SSS (SMD = −0.21; 95% CI: −0.40 to −0.01; %change: −20.34%) and the PDS (SMD = 0.49; 95% CI: 0.06 to 0.91; %change: 31.64%) in favor of the intervention group. In the pre–post analyses, there was an improvement in the SSS (SMD = −0.72; 95% CI: −1.10 to −0.34; %change: −15.65%) and the PDS (SMD = 0.47; 95% CI: 0.15 to 0.79; %change:18.98%).Conclusions: This meta‐analysis provides an overview of the evidence supporting exercise as a suitable intervention to reduce the severity of CIPN by reducing the severity of the symptoms and the peripheral deep sensitivity among patients with cancer or cancer survivors. Furthermore, sensoriomotor training and mind–body exercises appear to be more effective in reducing symptom severity, and active nerve‐specific exercises and mind–body exercises seem to be more effective in improving peripheral deep sensitivity.

1 May 2022 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Open access
SRSara Reina-Gutiérrez
Sara Reina-Gutiérrez
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
PMPurificación López Muñoz
Purificación López Muñoz
ATAna Torres-Costoso
Ana Torres-Costoso
There is overwhelming evidence regarding the beneficial effects of exercise on the management of symptoms, functionality and health-related quality of life (HRQoL) of people with multiple sclerosis (MS). However, few analyze have compared different types of exercise. The aim of this network meta-analysis (NMA) was to assess which type of physical exercise has the greatest positive effect on HRQoL in people with MS. MEDLINE, Cochrane Library, Embase, Web of Science, Physiotherapy Evidence Database and SPORTDiscus databases were searched from inception to June 2021 to identify randomized controlled trials (RCTs) examining the effect of physical exercise on HRQoL in people with MS. The NMA included pairwise and indirect comparisons. We ranked the effect of interventions calculating the surface under the cumulative ranking (SUCRA). We included 45 RCTs in this NMA (2428 participants; 76% women; mean age 45 years). Five types of physical exercises were ranked. Sensorimotor training had the highest effect size (0.87, 95% confidence interval [CI] 0.60; 1.15) and the highest SUCRA (87%) for total HRQoL. The highest effect size and SUCRA for physical and mental HRQoL were for aerobic exercise (0.85, 95% CI 0.28; 1.42) (89%) and mind-body exercises (0.54, 95% CI 0.03; 1.06) (89%). Sensorimotor training was the best exercise for mild disease and aerobic exercise for severe disease for total HRQoL. Sensorimotor training seems the most effective exercise to improve HRQoL and aerobic and mind-body exercises to improve physical and mental HRQoL, respectively.